
Brazil · Veterinary startup
Ourofino Saúde Animal is the largest veterinary-pharmaceutical group in Brazil, focused on enhancing animal health through science and innovation.
Funding reportedLast round: Secondary market
Ourofino Saúde Animal is the largest veterinary-pharmaceutical group in Brazil, focused on enhancing animal health through science and innovation.
Founded in 1987 by Norival Bonamichi and Jardel Massari, the company has grown from distributing veterinary supplies to manufacturing a wide range of veterinary medicinal products for both production animals and pets. With a modern factory in Cravinhos, São Paulo, Ourofino operates on a large scale, exporting to over 30 countries, primarily in the Americas. The company employs between 1,001 and 5,000 people and has the largest commercial team in Brazil dedicated to its distribution network. Ourofino's product portfolio includes ectoparasiticides, hormones, vaccines, and disinfectants, catering to various animals such as bovines, equines, poultry, swine, dogs, and cats. The company also has a specialized division, Ourofino PET, focusing on pet health solutions.
Funding, as reported
What they build
Known for
health careanimal health developmentanimal health products brazilconsumersanimal health technology solutionspet carebrazilian veterinary industrydistributionmanufacturinganimal health innovation latin americaanimal health industryveterinary medicinal productsanimal health product portfolioanimal health supply chainanimal health industry partnershipsinformation technology & services
Built with from their website
Google MapsAmazon SESGoogle Tag ManagerAutomic AutomationTableauACLWordPress.orgSalesforce CRM AnalyticsSalesforce Marketing CloudGoogle Ads
Clarity SDMFont AwesomeOpenSSLApacheElementorMicrosoft.netYouTubeSpotify
Add your raise, your deck and your story, and put Ourofino Saúde Animal in front of investors. Or tell us what we have wrong.